Analysis of low-molecular-weight metabolites in stomach cancer cells by a simplified and inexpensive GC/MS metabolomics method
Abstract GC/MS coupled metabolomics analysis, using a simplified and much less expensive silylation process with trimethylsilyl cyanide (TMSCN), was conducted to investigate metabolic abnormalities in stomach cancer cells. Under optimized conditions for derivatization by TMSCN and methanol extraction, 228 metabolites were detected using GC/MS spectrometry analysis, and 89 metabolites were identified using standard compounds and the NIST database. Ten metabolite levels were found to be lower in stomach cancer cells relative to normal cells. Among those ten metabolites, four metabolites—ribose, proline, pyroglutamic acid, and glucose—were known to be linked to cancers. In particular, pyroglutamic acid level showed a drastic reduction of 22-fold in stomach cancer cells. Since glutamine and glutamic acid are known to undergo cyclization to pyroglutamic acid, the 22-fold reduction might be the actual reduction in the levels of glutamine and/or glutamic acid—both known to be cancer-related. Hence, the marked reduction in pyroglutamic acid level might serve as a biomarker to aid early detection of stomach cancer. Graphical abstract.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:412 |
|---|---|
| Enthalten in: |
Analytical and bioanalytical chemistry - 412(2020), 12 vom: 18. März, Seite 2981-2991 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dai, Min [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
| doi: |
10.1007/s00216-020-02543-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR039597512 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR039597512 | ||
| 003 | DE-627 | ||
| 005 | 20230519155833.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00216-020-02543-6 |2 doi | |
| 035 | |a (DE-627)SPR039597512 | ||
| 035 | |a (SPR)s00216-020-02543-6-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 540 |a 570 |q ASE |
| 082 | 0 | 4 | |a 540 |q ASE |
| 084 | |a 35.23 |2 bkl | ||
| 084 | |a 35.71 |2 bkl | ||
| 084 | |a 42.03 |2 bkl | ||
| 100 | 1 | |a Dai, Min |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Analysis of low-molecular-weight metabolites in stomach cancer cells by a simplified and inexpensive GC/MS metabolomics method |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract GC/MS coupled metabolomics analysis, using a simplified and much less expensive silylation process with trimethylsilyl cyanide (TMSCN), was conducted to investigate metabolic abnormalities in stomach cancer cells. Under optimized conditions for derivatization by TMSCN and methanol extraction, 228 metabolites were detected using GC/MS spectrometry analysis, and 89 metabolites were identified using standard compounds and the NIST database. Ten metabolite levels were found to be lower in stomach cancer cells relative to normal cells. Among those ten metabolites, four metabolites—ribose, proline, pyroglutamic acid, and glucose—were known to be linked to cancers. In particular, pyroglutamic acid level showed a drastic reduction of 22-fold in stomach cancer cells. Since glutamine and glutamic acid are known to undergo cyclization to pyroglutamic acid, the 22-fold reduction might be the actual reduction in the levels of glutamine and/or glutamic acid—both known to be cancer-related. Hence, the marked reduction in pyroglutamic acid level might serve as a biomarker to aid early detection of stomach cancer. Graphical abstract | ||
| 650 | 4 | |a Stomach cancer cells |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Sample treatment |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a GC/MS |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Metabolomics |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Ma, Ting |e verfasserin |4 aut | |
| 700 | 1 | |a Niu, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Mengmeng |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Zhiwu |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Shaomin |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Hongmin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Analytical and bioanalytical chemistry |d Berlin : Springer, 2002 |g 412(2020), 12 vom: 18. März, Seite 2981-2991 |w (DE-627)SPR002080982 |w (DE-600)1459122-4 |x 1618-2650 |7 nnns |
| 773 | 1 | 8 | |g volume:412 |g year:2020 |g number:12 |g day:18 |g month:03 |g pages:2981-2991 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00216-020-02543-6 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.23 |q ASE |
| 936 | b | k | |a 35.71 |q ASE |
| 936 | b | k | |a 42.03 |q ASE |
| 951 | |a AR | ||
| 952 | |d 412 |j 2020 |e 12 |b 18 |c 03 |h 2981-2991 | ||